Alexander K.
- Country
- Germany
- Department
- Med. Klinik IV - Innere Medizin
Research Overview
- A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)
- Phase 3 Randomized Open‑Label Study of Elritercept Versus Epoetin Alfa for Anemia in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndromes Requiring RBC Transfusions
- Phase III Randomized Open-Label Study of Regorafenib and Nivolumab Versus Standard Chemotherapy in Refractory Advanced Gastro-Oesophageal Cancer
Data & Insights
Has run more than one trial at 197 of 509 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating various blood cancers and related conditions, with particular focus on acute lymphoblastic leukemia, chronic myeloid leukemia, and multiple myeloma.
- Philadelphia-Chromosome positive leukemia treatment
- Stem cell transplantation protocols
- Novel therapeutic combinations for multiple myeloma
Additional expertise includes research into myelodysplastic syndromes and innovative approaches for Hodgkin lymphoma management.
Gastrointestinal Oncology
Focuses on advanced treatments for colorectal cancer and gastro-oesophageal cancer, with emphasis on metastatic disease management.
- Post-resection chemotherapy strategies
- Targeted therapy combinations
- Novel treatment approaches for refractory cases
Particular interest in developing treatment protocols for patients with metastatic disease and exploring innovative therapeutic combinations.
Precision Medicine
Specializes in molecular-targeted therapies and personalized treatment approaches across various cancers.
- Circulating tumor DNA analysis
- Targeted therapy optimization
- Treatment response monitoring
Expertise in utilizing biomarker-driven approaches and developing therapeutic strategies based on molecular profiling.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.